Home » Topics » Regulatory » Patents

Patents
RSS

Oral antiinflammatory/analgesic compounds with reduced ulcerogenic potential

May 19, 1998

Helopharm describes improved class III antiarrhythmic agents

May 19, 1998

Antifungal agents disclosed by Nippon Soda

May 15, 1998

Novel isoquinolines prepared at Snow Brand Milk Products inhibit neuronal cell death

May 15, 1998

Banyu describes antimuscarinic piperidines with bronchodilating effects

May 14, 1998

Neuraminic acid derivatives claimed by Sankyo for influenza

May 14, 1998

Roche presents series with potent activity against HSV thymidine kinase

May 14, 1998

Na+/H+ exchange inhibitors claimed for ischemic and other disorders by Hoechst

May 14, 1998

Bis-imide antitumor agents developed at ADIR

May 14, 1998

New SERMs discovered at Lilly and claimed for estrogen-dependent disorders

May 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 22, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...